Letters
Endocrinology Scheme is the exception, and I have been impressed for some time with their use of gas chromatography-mass spectrometry (GC-MS) evaluation in the pursuit of accuracy goals, and with their general approach to the comparative evaluation of methods. I would, however, still question whether the users understand the concepts of the evaluation of the data being presented.
(a) A quick inspection of the annual report shows that a bias of + or -15% is allowed. This means that the highest reading method is giving results 30% higher than the lowest, but both are considered acceptable. (b) For two of the analytes the GC-MS data indicates that the all-laboratory trimmed mean (ALTM) is 9-11 % lower than the GC-MS target, but the AL TM is quoted on routine reports as the target value. (c) As the majority of users with high bias seem content to stay with their methods, do they understand what the results mean?
2 Oversight of EQA: I would not disagree with Jonathan's statement that the tried and tested mechanism works, even though the length of the sentence leaves me breathless. One of my objectives was to examine where EQA should be going, and I finished my article with a number of goals to be met. I am not clear who is addressing these goals in the current system. I am certainly not aware of consistent standards of performance being set. 2. In the discussion the use of the term 'acute secondary adrenal failure' was confusing as the post mortem finding of atrophic adrenals due to absent zona fasciculata and reticularis suggests a chronic adrenocorticotrophic hormone (ACTH) deficiency state in this patient. The secondary adrenocortical insufficiency was acutely revealed by the precipitating illness. This is not similar to acute loss of pituitary function due to trauma or pituitary apoplexy, as alluded to in the discussion, because in these conditions the adrenal cortices are anatomically normal.
3. The authors emphasize that this was a case of isolated ACTH deficiency, based on the anatomical absence of corticotrophs and the presence of numerous cells staining for other anterior pituitary hormones. They stated that the functional integrity of these cells has to be tested by appropriate stimulation tests in order to provide confirmatory evidence for their function or malfunction. However, the finding of a low total T4 and T3 with slightly raised thyroid stimulating hormone (TSH) in this case is consistent with secondary hypothyroidism due to thyrotroph malfunction. Furthermore, the finding of a serum growth hormone concentration of 2mU/L in the presence of severe hypo glycaemia (a potent Letters 115 stimulus for growth hormone secretion) confirms growth hormone deficiency due to somatotroph malfunction. It also suggests that growth hormone deficiency was a contributing factor to the severity and persistence of hypoglycaemia of pure glucocorticoid deficiency. Therefore, isolated ACTH deficiency was unlikely in this patient.
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